Zi Xiaolin, Lusch Achim, Blair Christopher A, Okhunov Zhamshid, Yokoyama Noriko N, Liu Shuman, Baker Molly, Huynh Victor, Landman Jaime
Department of Urology, University of California, Irvine, CA 92868, USA.
Oncotarget. 2016 Aug 16;7(33):53277-53288. doi: 10.18632/oncotarget.10467.
To investigate the cellular and molecular interactions between clear-cell renal cell carcinoma (ccRCC) and perinephric adipose tissue (PAT), perineoplasm PAT, PAT away from the neoplasm, renal sinus and subcutaneous adipose tissues were collected at the time of renal surgery for renal masses and conditioned medium (CM) was generated from 62 patients. Perineoplasm PAT CMs from 44 out of 62 (about 71%) of patients with ccRCC or benign renal diseases (e.g. oncocytomas, angiomyolipomas, multicystic kidney, interstitial fibrosis, etc.) enhanced the migration of CaKi-2 cells. Perineoplasm PAT CMs from ccRCC significantly increased migration of ACHN and CaKi-2 cells by ~8.2 and ~2.4 folds, respectively, relative to those from benign renal diseases, whereas there is no significant difference in migration between ccRCC and benign renal diseases in CMs collected from culturing PAT away from neoplasm, renal sinus and subcutaneous adipose tissues. High Fuhrman Grade was associated with increased migration of Caki-2 cells by perineoplasm PAT CMs. Perineoplasm PATs from pT3 RCCs overexpressed multiple WNTs and their CMs exhibited higher WNT/ß-catenin activity and increased the migration of Caki-2 cells compared to CMs from benign neoplasms. Addition of secreted WNT inhibitory factor-1 recombinant protein into perineoplasm PAT CMs completely blocked the cell migration. These results indicate that WNT related factors from perineoplasm PAT may promote progression of local ccRCC to locally advanced (pT3) disease by increasing ccRCC cell mobility.
为了研究透明细胞肾细胞癌(ccRCC)与肾周脂肪组织(PAT)之间的细胞和分子相互作用,在肾脏肿块肾手术时收集肿瘤周围PAT、远离肿瘤的PAT、肾窦和皮下脂肪组织,并从62例患者中制备条件培养基(CM)。62例ccRCC或良性肾脏疾病(如嗜酸性细胞瘤、血管平滑肌脂肪瘤、多囊肾、间质纤维化等)患者中,44例(约71%)的肿瘤周围PAT的CM增强了CaKi-2细胞的迁移。相对于良性肾脏疾病患者的肿瘤周围PAT的CM,ccRCC患者的肿瘤周围PAT的CM分别使ACHN和CaKi-2细胞的迁移显著增加了约8.2倍和约2.4倍,而从远离肿瘤、肾窦和皮下脂肪组织培养的PAT收集的CM中,ccRCC和良性肾脏疾病在迁移方面没有显著差异。高Fuhrman分级与肿瘤周围PAT的CM使Caki-2细胞迁移增加有关。与良性肿瘤的CM相比,pT3 RCC的肿瘤周围PAT过表达多种WNTs,其CM表现出更高的WNT/β-连环蛋白活性,并增加了Caki-2细胞的迁移。向肿瘤周围PAT的CM中添加分泌型WNT抑制因子-1重组蛋白可完全阻断细胞迁移。这些结果表明,肿瘤周围PAT中的WNT相关因子可能通过增加ccRCC细胞的迁移能力促进局部ccRCC进展为局部晚期(pT3)疾病。